Author | James Larkin, MD, PhD | OncLive

Author | James Larkin, MD, PhD

Articles

Dr. Larkin on Lenvatinib Plus Everolimus in Patients With RCC

September 15, 2015

Video

James Larkin, MD, PhD, medical oncologist, Royal Marsden Hospital, discusses a phase II study that examined the combination of lenvatinib and everolimus versus either agent alone in patients with renal cell carcinoma.

x